GHRH receptor is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.
Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.
CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.
Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.
The second form adds a maleimide-bearing linker to the lysine at the carboxyl end. This group reacts with cysteine-34 on circulating serum albumin, forming a covalent bond that keeps the peptide in the bloodstream for far longer. ConjuChem developed the molecule as a way to extend the action of a peptide without frequent administration. The albumin attachment is the defining structural feature of the drug affinity complex version. Whether continuous exposure produces effects distinct from shorter pulses remains an unresolved research question.
CJC-1295 acts at the growth hormone-releasing hormone receptor, a G-protein-coupled receptor found on somatotroph cells in the anterior pituitary. Binding triggers a rise in cyclic AMP and calcium entry, which promotes release of stored growth hormone. Because the peptide mimics the body's own releasing hormone, it amplifies existing secretory pulses rather than driving continuous output. The size of the response therefore depends partly on the subject's own hormonal rhythm and feedback state.
The attached maleimide group explains the unusual duration of the DAC version. After injection it reacts with the thiol of cysteine-34 on serum albumin, forming a stable covalent bond. The resulting conjugate is too large for rapid kidney filtration and is shielded from many peptidases. Reported half-lives for this form reach several days, whereas the version without the group is cleared in roughly half an hour. That gap is the main pharmacological difference between the two.
| Property | Value | Notes |
|---|---|---|
| Primary target | GHRH receptor | G-protein-coupled receptor on pituitary somatotrophs |
| Half-life, long-acting form | Several days | Extended by covalent albumin binding |
| Half-life, short form | About 30 minutes | Cleared rapidly by peptidases and kidneys |
| Route in studies | Subcutaneous injection | Used in the published human trials |
| Main measured effect | Rise in GH and IGF-1 | Surrogate markers rather than clinical endpoints |
=== Synthetic alizarin 1868 – 1873 === The development of synthetic alizarin opened up a huge market that was formerly served by natural dye makers. Alizarin was the first dye whose structure chemist determined, and they quickly set it as a target of synthesis, succeeding by 1868. Other chemical components of natural madder were identified and applied by the mid-19th century, including purpurin, which produced a delicate lilac colour, and green alizarin, which was patented in Britain and famously displayed at the 1867 Paris International Exhibition. Similar to aniline dyes, the precursors for Synthetic Alizarin were easily obtainable from coal tar. Germany dominated the synthetic alizarin market, however foreign competition was not non-extant, for example the British Alizarine Company Ltd.
Leo Tolstoy's epic novel War and Peace recounts Napoleon's wars between 1805 and 1812 (especially the disastrous 1812 invasion of Russia and subsequent retreat) from a Russian perspective. Stendhal's novel The Charterhouse of Parma opens with a ground-level recounting of the Battle of Waterloo and the subsequent chaotic retreat of French forces. Les Misérables by Victor Hugo takes place against the backdrop of the Napoleonic Wars and subsequent decades, and in its unabridged form contains an epic telling of the Battle of Waterloo. Adieu is a novella by Honoré de Balzac in which can be found a short description of the French retreat from Russia, particularly the battle of Berezina, where the fictional couple of the story are tragically separated. Years later after imprisonment, the husband returns to find his wife still in a state of utter shock and amnesia. He has the battle and their separation reenacted, hoping the memory will heal her state. William Makepeace Thackeray's novel Vanity Fair takes place during the 1815 Napoleonic War – one of its protagonists dies at the Battle of Waterloo. Thackeray states in Chapter XXX "We do not claim to rank among the military novelists. Our place is with the non-combatants. When the decks are cleared for action we go below and wait meekly." And indeed he presents no descriptions of military leaders, strategy, or combat; he describes anxious non-combatants waiting in Brussels for news.
==== United Kingdom ==== Estimates show that in 2024 there were nearly a million people living with AD and other dementias in the UK, with more than 800,000 in England. This is expected to rise to 1.4 million by 2040. In 2022 and 2023, dementia was the leading cause of death in England and Wales.
Sources: en.wikipedia.org
=== Cannabis === On May 31, 2019, the Illinois General Assembly passed the Illinois Cannabis Regulation and Tax Act legalizing and regulating the production, consumption, and sale of adult-use cannabis. On June 25, 2019, Pritzker signed the legislation into law, which went into effect on January 1, 2020. Illinois was the 11th U.S. state to legalize recreational use of cannabis. Criminal records of people caught possessing less than 30 grams were cleared. Tax revenue collected from cannabis sales is used to invest in impoverished communities affected by the war on drugs and in drug rehabilitation programs. After the first month of legalization, cannabis sales generated approximately $10.4 million in tax revenue. Cannabis sales were over $52 million by July 2020, $445.3 million by the end of 2022, and $2 billion by the end of 2024, which generated about $490 million in sales tax revenue. On December 31, 2019, Pritzker pardoned approximately 11,000 people for low-level cannabis convictions. In 2020, Pritzker pardoned an additional 9,200 people with low-level cannabis convictions and expunged the arrest records of 490,000 convictions related to cannabis.
In December 2008, the 3d BCT deployed to Baghdad, Iraq and redeployed to Ft. Bragg in November 2009. In August 2009, 1st BCT deployed once again to Iraq and redeployed late July 2010. During the months of August and September 2009, 4th BCT deployed again to Afghanistan and returned in August 2010 having lost 38 soldiers. In May 2011 1–505 (Task Force 1 Panther) deployed to Afghanistan in support of Operation Enduring Freedom. Dispersed throughout the country, 1st battalion was attached to various Special Operations elements. 1st battalion redeployed to Fort Bragg, NC in February 2012 having lost two paratroopers. The 2d Brigade deployed to the Al Anbar Governorate in Iraq in May 2011, for the last time, as part of Operation New Dawn. Its mission was to advise, train and assist the Iraqi Armed Forces and Ministry of the Interior forces, as part of the withdrawal of United States Forces – Iraq. Elements of 2d Brigade were among the last US combat units to withdraw from Baghdad. The brigade suffered the loss of the last American service member in Iraq, SPC. David E. Hickman, on 14 November 2011. They were part of the long convoy of equipment and troops who exited Iraq into Kuwait as OIF came to an end.
The kraken is a legendary sea monster of giant proportions said to dwell off the coasts of Norway and Greenland, usually portrayed in art as a giant cephalopod attacking ships. Linnaeus included it in the first edition of his 1735 Systema Naturae. In a Hawaiian creation myth that says the present cosmos is the last of a series which arose in stages from the ruins of the previous universe, the octopus is the lone survivor of the previous, alien universe. The Akkorokamui is a gigantic tentacled monster from Ainu folklore. A battle with an octopus plays a significant role in Victor Hugo's book Travailleurs de la mer (Toilers of the Sea), relating to his time in exile on Guernsey. Ian Fleming's 1966 short story collection Octopussy and The Living Daylights, and the 1983 James Bond film were partly inspired by Hugo's book. Japanese erotic art, shunga, includes ukiyo-e woodblock prints such as Katsushika Hokusai's 1814 print Tako to ama (The Dream of the Fisherman's Wife), in which an ama diver is sexually intertwined with a large and a small octopus. The print is a forerunner of tentacle erotica. Its many arms that emanate from a common center means that the octopus is sometimes used to symbolize a powerful and manipulative organization.
Sources: en.wikipedia.org
It binds the growth hormone-releasing hormone receptor on pituitary somatotroph cells. Receptor activation raises cyclic AMP and promotes release of stored growth hormone granules. Because the peptide persists longer than natural releasing hormone, stimulation is prolonged rather than brief.
The drug affinity complex links the peptide to serum albumin through a covalent bond. The conjugate is too large to be filtered quickly by the kidneys and is shielded from enzymatic breakdown. This extends the apparent half-life from roughly minutes to several days.
Long-term safety and any clinical benefit are unestablished. Published human data cover small groups over limited periods and focus on hormone levels rather than health outcomes. Whether prolonged elevation of growth hormone and insulin-like growth factor 1 is beneficial or harmful is an open question.